|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Short-term bank deposits | |||||||||||||||
| Short-term marketable securities | |||||||||||||||
| Trade receivables | |||||||||||||||
| Other receivables and prepaid expenses | |||||||||||||||
| Inventories | |||||||||||||||
| Total current assets | |||||||||||||||
| LONG-TERM ASSETS: | |||||||||||||||
| Long-term trade receivables | |||||||||||||||
| Long-term marketable securities | |||||||||||||||
| Long-term financial investments | |||||||||||||||
| Deferred tax assets | |||||||||||||||
| Operating lease right-of-use assets | |||||||||||||||
| Severance pay funds | |||||||||||||||
| Total long-term assets | |||||||||||||||
| PROPERTY AND EQUIPMENT, NET | |||||||||||||||
| INTANGIBLE ASSETS, NET | |||||||||||||||
| GOODWILL | |||||||||||||||
| Total assets | |||||||||||||||
| CURRENT LIABILITIES: | |||||||||||||||
| Trade payables | |||||||||||||||
| Other payables and accrued expenses | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Short-term operating lease liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| LONG-TERM LIABILITIES: | |||||||||||||||
| Accrued severance pay | |||||||||||||||
| Deferred revenues and other liabilities | |||||||||||||||
| Long-term operating lease liabilities | |||||||||||||||
| Total long-term liabilities | |||||||||||||||
| Unlabeled Abstract | |||||||||||||||
| Total liabilities | |||||||||||||||
| SHAREHOLDERS’ EQUITY: | |||||||||||||||
| Ordinary shares of NIS 0.01 par value authorized: 200,000,000 and 200,000,000 shares as of December 31, 2025 and 2024, respectively; Issued: 65,730,082 and 65,170,217 shares as of December 31, 2025 and 2024, respectively; Outstanding: 27,089,259 and 29,679,755 shares as of December 31, 2025 and 2024, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Treasury stock at cost – 38,640,823 and 35,490,462 shares as of December 31, 2025 and 2024, respectively | |||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||
| Retained earnings | |||||||||||||||
| Total shareholders’ equity | |||||||||||||||
| Total liabilities and shareholders’ equity | |||||||||||||||
Loading...